Kevin Emancipator

Kevin Emancipator is a multifaceted professional with a background in bioengineering, healthcare strategy, and project management.1 He currently serves as the Director of External Innovation at Daiichi Sankyo, Inc., a role he recently assumed after joining the company's Global Business Development team.5

Education and Background

Kevin holds an MBA from Harvard Business School.16 Prior to his MBA, he graduated from the Jerome Fisher Program, which suggests a strong foundation in both engineering and business.

Professional Experience

Current Role:: As the Director of External Innovation at Daiichi Sankyo, Inc., Kevin is likely involved in identifying and evaluating external opportunities for innovation and collaboration in the pharmaceutical industry.

Previous Experiences::

• Before joining Daiichi Sankyo, Kevin had experience in business analytics and insights.2
• He has demonstrated interest and expertise in life science business development.3

Areas of Focus

Kevin's professional interests and expertise span several areas:

1. Bioengineering: His educational background and current role suggest a strong foundation in bioengineering.1
2. Healthcare Strategy: He has experience in strategic planning within the healthcare sector.1
3. Project Management: Kevin has skills in managing complex projects.1
4. Business Development: His current role and past experiences indicate a focus on business development in the life sciences industry.35

Notable Projects

Kevin has been involved with DoriVac, a personalized cancer vaccine project. This innovative approach aims to boost antigen-specific immune responses in cancer treatment.4 He served as the Chief Business Officer (CBO) for the DoriVac team, which was recognized by Harvard Business School as one of eight finalist teams in a venture competition.67

Kevin Emancipator's diverse skill set, combining scientific knowledge with business acumen, positions him well for his role in external innovation at Daiichi Sankyo, where he likely contributes to the company's efforts in advancing pharmaceutical research and development through strategic partnerships and innovative projects.